Review of Well Health Technologies

MAY 22, 2025 - WELL’s management is actively providing shareholders a better picture of the value of its holdings and subsidiaries, as management believes the public market currently undervalues WELL’s share price. WELL’s leverage level is at the higher end of the historical averages, which we would prefer to see come down over the near term, either through organic earnings growth or debt repayment. In addition, WELL’s recent operating results are quite strong, and the company is a name that has limited exposure to the trade war uncertainty. WELL also has some potential catalysts for upside potential, as some of its subsidiaries are expected to go through initial public offerings (IPO) in the near term. We think investors could do well owning WELL over the next three to five years as the company continues to execute its growth playbook. We are maintaining our rating of ‘B+’.

Download Report

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.